Zobrazeno 1 - 10
of 353
pro vyhledávání: '"Aubrey Manack"'
Autor:
Andrew M. Blumenfeld, Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Olivia Hughes, Brett Dabruzzo, Aubrey Manack Adams, Merle Diamond
Publikováno v:
Pain and Therapy, Vol 13, Iss 6, Pp 1571-1587 (2024)
Abstract Introduction Combination use of atogepant and onabotulinumtoxinA has the potential to be more effective than either alone for the preventive treatment of chronic migraine (CM) due to their complementary mechanisms of action. This analysis co
Externí odkaz:
https://doaj.org/article/9bb21333a6b9477695cc5d48969da9f6
Autor:
Michel Lanteri-Minet, Elizabeth Leroux, Zaza Katsarava, Richard B. Lipton, Fumihiko Sakai, Manjit Matharu, Kristina Fanning, Aubrey Manack Adams, Katherine Sommer, Michael Seminerio, Dawn C. Buse
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Objective To assess rates of traversing barriers to care to access optimal clinical outcomes in people with migraine internationally. Background People in need of medical care for migraine should consult a health care professional knowledgea
Externí odkaz:
https://doaj.org/article/35d3951a2ed94226982c1beef0ccd5ab
Autor:
Richard B. Lipton, Michel Lanteri-Minet, Elizabeth Leroux, Aubrey Manack Adams, Janette Contreras-De Lama, Michael L. Reed, Kristina M. Fanning, Dawn C. Buse
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Individuals with migraine frequently experience pre- and post-headache symptoms. This analysis aimed to characterize the relative frequency and burden of pre- and post-headache symptoms in people with migraine using data collected
Externí odkaz:
https://doaj.org/article/0e21e9a15c754aaaa9db1d6f68b8daaf
Autor:
Richard B. Lipton, Janette Contreras-De Lama, Daniel Serrano, Ella Engstrom, Nicolai D. Ayasse, Weijie Poh, François Cadiou, Aubrey Manack Adams
Publikováno v:
Neurology and Therapy, Vol 13, Iss 1, Pp 69-83 (2023)
Abstract Introduction Although acute and preventive treatments for migraine are commonly given in combination, data on the real-world effectiveness of ubrogepant as an acute treatment when used with an anti-calcitonin gene-related peptide (CGRP) mono
Externí odkaz:
https://doaj.org/article/46bc07f4fffd4cdbb7cd0702276877e5
Autor:
Andrew M. Blumenfeld, Richard B. Lipton, Stephen Silberstein, Stewart J. Tepper, Larry Charleston, Stephen Landy, Deena E. Kuruvilla, Aubrey Manack Adams
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1533-1551 (2023)
Abstract Migraine is a neurologic disease with a complex pathophysiology that can be controlled with current treatment options but not cured. Therefore, treatment expectations are highly variable. The concept of migraine freedom was recently introduc
Externí odkaz:
https://doaj.org/article/bb3f6e1700ef433e92ce463429385b39
Autor:
Aubrey Manack Adams, Susan Hutchinson, Ella Engstrom, Nicolai D. Ayasse, Daniel Serrano, Linda Davis, Katherine Sommer, Janette Contreras-De Lama, Richard B. Lipton
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-8 (2023)
Abstract Background Individuals using onabotulinumtoxinA as a preventive migraine treatment often use acute treatments for breakthrough attacks. Data on real-world effectiveness of the small-molecule calcitonin gene–related peptide (CGRP) receptor
Externí odkaz:
https://doaj.org/article/798c4497f6f544a296044c0039fea9f6
Autor:
Stephen D. Silberstein, Hans-Christoph Diener, David W. Dodick, Aubrey Manack Adams, Ronald E. DeGryse, Richard B. Lipton
Publikováno v:
Pain and Therapy, Vol 9, Iss 2, Pp 695-707 (2020)
Abstract Introduction The phase 3 PREEMPT trials demonstrated efficacy and tolerability of onabotulinumtoxinA for headache prevention in adults with chronic migraine. OnabotulinumtoxinA significantly reduced headache frequency from baseline vs. place
Externí odkaz:
https://doaj.org/article/ef98da12878347bd8fce948f3b33ed98
Autor:
Hans-Christoph Diener, David W. Dodick, Richard B. Lipton, Aubrey Manack Adams, Ronald E. DeGryse, Stephen D. Silberstein
Publikováno v:
Pain and Therapy, Vol 9, Iss 2, Pp 683-694 (2020)
Abstract Introduction The double-blind, phase 3 PREEMPT trials demonstrated the efficacy and tolerability of onabotulinumtoxinA for headache prevention in adults with chronic migraine. This post hoc analysis evaluated the effect of onabotulinumtoxinA
Externí odkaz:
https://doaj.org/article/419561ad40d04eef9c309aa4c24b6096
Autor:
Laszlo Mechtler, Nicolas Saikali, Jennifer McVige, Olivia Hughes, Alexandra Traut, Aubrey Manack Adams
Publikováno v:
Frontiers in Neurology, Vol 12 (2022)
Background: OnabotulinumtoxinA and calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) target different migraine pathways, therefore, combination treatment may provide additional effectiveness for the preventive treatment of chronic m
Externí odkaz:
https://doaj.org/article/a85d0e8e61494530a6625c1d26a5f06f
Autor:
William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background OnabotulinumtoxinA is effective in preventing chronic migraine (CM); however, the benefit of onabotulinumtoxinA in patients with CM with daily headache is unknown because these patients are typically excluded from clinical trials.
Externí odkaz:
https://doaj.org/article/fe8740504e1e4f8da398ab5cc3ea9155